69088 Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices 

Dated: November 1, 2010. 

Christy Thomsen, 

Director, Office of Communications and 

Public Liaison, National Center for 

Complementary and Alternative Medicine, 

National Institutes of Health. 

[FR Doc. 2010–28290 Filed 11–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Strengthening Communities 

Fund (SCF) Evaluation. 

OMB No.: New Collection. 

Description: This proposed 

information collection activity is to 

obtain information from participants in 

two Strengthening Communities Fund 

(SCF) programs: The Nonprofit Capacity 

Building Program and the State, Local, 

and Tribal Government Capacity 

Building Program. Both programs are 

designed to contribute to the economic 

recovery as authorized in the American 

Recovery and Reinvestment Act of 2009 

(ARRA). The SCF evaluation is an 

important opportunity to examine 

outcomes achieved by the Strengthening 

Communities Fund and progress toward 

the objective of improving the capacity 

of organizations served by program 

grantees to address broad economic 

recovery issues in their communities. 

The evaluation will be designed to 

assess progress and measure increased 

organizational capacity of each 

participating organization. The purpose 

of this request is to receive approval of 

the data collection instruments that will 

be used in this study. 

A significant amount of information is 

already being collected through 

program-specific OMB-approved PPR 

forms or is available through secondary 

sources. Proposed surveys and phone 

interviews are very brief to reduce the 

burden on respondents. 

Respondents: SCF grantees,and faithbased and Community Organizations 

(FBCOs). 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

An on-line survey of SCF grantees ................................................................. 84 1 0.25 21 

Telephone interview of SCF grantees ............................................................. 84 1 1.50 126 

On-line survey of faith-based and community organizations (FBCOs) that 

received capacity building services from the SCF grantees ....................... 1,000 1 0.50 500 

Estimated Total Annual Burden 

Hours: 647 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: November 4, 2010. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2010–28304 Filed 11–9–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–P–0273] 

Determination That Amphetamine 

Sulfate, 5 and 10 Milligram Tablets, 

Was Not Withdrawn From Sale for 

Reasons of Safety or Effectiveness 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) has determined 

that Amphetamine sulfate, 5 and 10 

milligram (mg) tablets, was not 

withdrawn from sale for reasons of 

safety or effectiveness. This 

determination will allow FDA to 

approve abbreviated new drug 

applications (ANDAs) for Amphetamine 

sulfate, 5 mg and 10 mg tablets, if all 

other legal and regulatory requirements 

are met. 

FOR FURTHER INFORMATION CONTACT: 

Patrick Raulerson, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 51, Rm. 6368, 

Silver Spring, MD 20993–0002, 301– 

796–3522. 

SUPPLEMENTARY INFORMATION: In 1984, 

Congress enacted the Drug Price 

Competition and Patent Term 

Restoration Act of 1984 (Pub. L. 98–417) 

(the 1984 amendments), which 

authorized the approval of duplicate 

versions of drug products approved 

under an ANDA procedure. ANDA 

applicants must, with certain 

exceptions, show that the drug for 

which they are seeking approval 

contains the same active ingredient in 

the same strength and dosage form as 

the ‘‘listed drug,’’ which is a version of 

the drug that was previously approved. 

ANDA applicants do not have to repeat 

the extensive clinical testing otherwise 

necessary to gain approval of a new 

drug application (NDA). The only 

clinical data required in an ANDA are 

data to show that the drug that is the 

subject of the ANDA is bioequivalent to 

the listed drug. 


emcdonald on DSK2BSOYB1PROD with NOTICES